SMS Group has backed a $19.5m series C for Omeicos Therapeutics to enable the Helmholtz spinout to advance its treatment for atrial fibrillation into a phase 2 trial.

Orchard Therapeutics has listed in the US following a $200m initial public offering that came just three years after the gene therapy developer was spun out of UCL.

A roundup of all the latest news on www.globalcorporateventuring.com for our subscribers.

Rich Ferrie has bid farewell to University of Manchester after 14 years to join University College Cork's tech transfer operation.

Idea Fund has provided seed capital for SciArt Software, a spinout of Wisconsin-Madison that has developed a weight reduction tool for engineering structures.

Significant Capital Ventures was officially launched this week to invest in seed-stage spinouts emerging out of five Australian universities.

UCL Technology Fund-backed gene therapy developer Orchard Therapeutics raised $200m in an offering that could possibly close at $230m.

Ariel University spinout Innoging has made its public debut and will commercialise ultrasound technology that lets radiologists manipulate scans without the patient being present.

Leiden University has backed a series A round co-led by Evonik and VisVires New Protein.

Oxford spinout Argonaut Therapeutics has received $2.6m from JW Pharmaceuticals in return for a 25% stake.